Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.
Masahiro KamataYoshihide AsanoRino ShidaNarumi MaedaAyumi YoshizakiTomomitsu MiyagakiTomohiko KawashimaYayoi TadaShinichi SatoPublished in: The Journal of dermatology (2019)